BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

563 related articles for article (PubMed ID: 20735414)

  • 1. Aiming drug discovery at lysophosphatidic acid targets.
    Tigyi G
    Br J Pharmacol; 2010 Sep; 161(2):241-70. PubMed ID: 20735414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysophospholipid-Related Diseases and PPARĪ³ Signaling Pathway.
    Tsukahara T; Matsuda Y; Haniu H
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29258184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysophospholipid growth factors and their G protein-coupled receptors in immunity, coronary artery disease, and cancer.
    Goetzl EJ; Graeler M; Huang MC; Shankar G
    ScientificWorldJournal; 2002 Feb; 2():324-38. PubMed ID: 12806020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysophosphatidic acid receptor (LPAR) modulators: The current pharmacological toolbox.
    Llona-Minguez S; Ghassemian A; Helleday T
    Prog Lipid Res; 2015 Apr; 58():51-75. PubMed ID: 25704399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysophosphatidic acid as a lipid mediator with multiple biological actions.
    Aikawa S; Hashimoto T; Kano K; Aoki J
    J Biochem; 2015 Feb; 157(2):81-9. PubMed ID: 25500504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous lysophosphatidic acid (LPA
    Sattikar A; Dowling MR; Rosethorne EM
    Br J Pharmacol; 2017 Feb; 174(3):227-237. PubMed ID: 27864940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Function and biological activities of the autotaxin-LPA axis].
    Li ZW; Zhao YR; Zhao C; Fu R; Li ZY
    Sheng Li Xue Bao; 2011 Dec; 63(6):601-10. PubMed ID: 22193457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lysophosphatidic acid: a "bioactive" phospholipid].
    Saulnier-Blache JS
    Med Sci (Paris); 2004; 20(8-9):799-803. PubMed ID: 15361348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurobiology of the Edg2 lysophosphatidic acid receptor.
    Yoshida A; Ueda H
    Jpn J Pharmacol; 2001 Oct; 87(2):104-9. PubMed ID: 11700008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysophosphatidic acid is a bioactive mediator in ovarian cancer.
    Fang X; Schummer M; Mao M; Yu S; Tabassam FH; Swaby R; Hasegawa Y; Tanyi JL; LaPushin R; Eder A; Jaffe R; Erickson J; Mills GB
    Biochim Biophys Acta; 2002 May; 1582(1-3):257-64. PubMed ID: 12069836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysophosphatidic Acid Signaling in Cancer Cells: What Makes LPA So Special?
    Balijepalli P; Sitton CC; Meier KE
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid.
    Bandoh K; Aoki J; Hosono H; Kobayashi S; Kobayashi T; Murakami-Murofushi K; Tsujimoto M; Arai H; Inoue K
    J Biol Chem; 1999 Sep; 274(39):27776-85. PubMed ID: 10488122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LPA and its analogs-attractive tools for elucidation of LPA biology and drug development.
    Kano K; Arima N; Ohgami M; Aoki J
    Curr Med Chem; 2008; 15(21):2122-31. PubMed ID: 18781939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereochemical properties of lysophosphatidic acid receptor activation and metabolism.
    Yokoyama K; Baker DL; Virag T; Liliom K; Byun HS; Tigyi G; Bittman R
    Biochim Biophys Acta; 2002 May; 1582(1-3):295-308. PubMed ID: 12069841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural insights into ligand recognition by the lysophosphatidic acid receptor LPA
    Taniguchi R; Inoue A; Sayama M; Uwamizu A; Yamashita K; Hirata K; Yoshida M; Tanaka Y; Kato HE; Nakada-Nakura Y; Otani Y; Nishizawa T; Doi T; Ohwada T; Ishitani R; Aoki J; Nureki O
    Nature; 2017 Aug; 548(7667):356-360. PubMed ID: 28792932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysophosphatidic acid and its role in reproduction.
    Budnik LT; Mukhopadhyay AK
    Biol Reprod; 2002 Apr; 66(4):859-65. PubMed ID: 11906902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A growing family of receptor genes for lysophosphatidic acid (LPA) and other lysophospholipids (LPs).
    Chun J; Contos JJ; Munroe D
    Cell Biochem Biophys; 1999; 30(2):213-42. PubMed ID: 10356643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysophospholipid activation of G protein-coupled receptors.
    Mutoh T; Chun J
    Subcell Biochem; 2008; 49():269-97. PubMed ID: 18751915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysophosphatidic acid is a lipid mediator with wide range of biological activities. Biosynthetic pathways and mechanism of action.
    Berdichevets IN; Tyazhelova TV; Shimshilashvili KhR; Rogaev EI
    Biochemistry (Mosc); 2010 Sep; 75(9):1088-97. PubMed ID: 21077828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The human lipid phosphate phosphatase-3 decreases the growth, survival, and tumorigenesis of ovarian cancer cells: validation of the lysophosphatidic acid signaling cascade as a target for therapy in ovarian cancer.
    Tanyi JL; Morris AJ; Wolf JK; Fang X; Hasegawa Y; Lapushin R; Auersperg N; Sigal YJ; Newman RA; Felix EA; Atkinson EN; Mills GB
    Cancer Res; 2003 Mar; 63(5):1073-82. PubMed ID: 12615725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.